Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
18/06/2025
UAE AI company G42: Collaborate to promote the creation, training, and commercialization of generative artificial intelligence solutions.
Latest
6 m ago
Raw sugar futures fell around 3.1%, while Arabica coffee futures fell more than 2.6%.
6 m ago
Los Angeles Mayor BASS lifts the curfew in Downtown Los Angeles.
8 m ago
The U.S. Food and Drug Administration (FDA) announced a new "National Priority Voucher Program" aimed at shortening the drug review time for companies that it deems to support national interests to one to two months. On June 17th, the FDA stated that the National Priority Voucher Program aims to significantly reduce the drug review time from the current average of 10-12 months. The FDA stated that in the first year of the program, they plan to issue a limited number of vouchers to companies that meet the criteria of "U.S. National Priority."
8 m ago
The FDA announced a new program to shorten drug review times to two months.
11 m ago
French President Macron: The Group of Seven needs to engage with influential partners.
See all latest